News Archive

28 Nov 2023

RoslinCT to manufacture world’s-first CRISPR-based therapy for Vertex

18 Sep 2023

Cell and Gene Therapy Catapult launch network for the advanced therapies industry in Scotland

07 Jun 2023

Cell and Gene Therapy Catapult opens new space on Edinburgh BioQuarter

30 Mar 2023

RoslinCT granted commercial manufacturing license

14 Sep 2022

Lykan Bioscience and RoslinCT announce Scientific Advisory Board

05 Sep 2022

ESGCT 29th Congress, in collaboration with BSGCT: 11 to 14th October 2022

UK Advanced Therapies Network: Monday 10th October 2022, 3pm to 6pm

04 Aug 2022

RoslinCT and Lykan Bioscience combine to create leading Advanced Cell Therapy CDMO

25 May 2022

RoslinCT announces appointment of Peter Coleman as CEO

11 Jan 2022

GHO Capital invests in RoslinCT, a leading cell therapy CDMO